O36.8213 Fetal anemia and thrombocytopenia, first trimester, fetus 3

Name of the Condition

• Fetal anemia and thrombocytopenia, first trimester, fetus 3
• Technical ICD term: O36.8213

Summary

This condition involves reduced red blood cell count (anemia) and low platelet levels (thrombocytopenia) in the fetus during the first trimester of pregnancy, specifically affecting a third fetus in a multiple gestation. It requires careful monitoring due to potential impacts on fetal development and pregnancy outcomes.

Causes

Fetal anemia can result from maternal-fetal blood type incompatibility, inherited red blood cell disorders, or placental abnormalities. Thrombocytopenia may stem from immune-mediated processes, infections, or genetic conditions affecting platelet production. Specific causes depend on individual clinical factors.

Risk Factors

• Maternal conditions such as autoimmune disorders or infections.
• Family history of blood-related genetic disorders.
• Exposure to substances or medications that impact fetal blood cell development.
• Prior pregnancy complications involving fetal blood abnormalities.
• Multiple gestation, which may increase risk for specific fetal complications.

Symptoms

Fetal symptoms are not directly observable, but prenatal care may reveal abnormal ultrasound findings, such as increased blood flow in fetal vessels or signs of growth restriction.

Diagnosis

Diagnosis typically involves prenatal ultrasound with Doppler studies to assess blood flow, maternal blood tests for antibody screening, and, if indicated, invasive testing like chorionic villus sampling or cordocentesis to evaluate fetal blood counts.

Treatment Options

Management may include close monitoring, maternal treatments to address underlying causes, and, in severe cases, fetal interventions such as intrauterine transfusions. Specific approaches depend on the severity and underlying etiology.

Prognosis and Follow-Up

Prognosis varies based on the cause and severity of the condition. Regular prenatal monitoring is essential to assess fetal well-being and adjust care as needed. Long-term follow-up may be required for affected infants.

Complications

Potential complications include fetal growth restriction, preterm delivery, or increased risk of bleeding due to thrombocytopenia. Severe cases may lead to hydrops fetalis or other serious outcomes.

Lifestyle & Prevention

While lifestyle changes alone cannot prevent this condition, maintaining regular prenatal care and avoiding known teratogens may support overall fetal health. Managing maternal health conditions can reduce associated risks.

When to Seek Professional Help

Seek medical attention if prenatal monitoring reveals abnormal findings, such as unusual ultrasound results or changes in fetal movement. Prompt evaluation is important for timely intervention.

Tips for Medical Coders

Document the specific trimester (first trimester) and the number of fetuses affected (fetus 3) to ensure accurate coding. Include details about diagnostic tests, maternal factors, and any interventions performed to support clinical specificity.